Acupuncture for Chronic Low Back Pain in Older Adults: A Randomized Clinical Trial
1. In older adults with chronic low back pain (CLBP), both standard and enhanced acupuncture treatments significantly improved disability compared...
Chronic Disease
Reports of high-impact chronic disease studies by medical professionals
Spironolactone does not reduce cardiovascular events in patients receiving maintenance dialysis
1. Cardiovascular mortality and heart failure-related hospitalization were similar in both groups. 2. There was no statistically significant difference between...
The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn’s Disease
1. In children with Crohn’s disease (CD), sarcopenia at diagnosis was associated with a greater chance of relapse in the...
Effectiveness and user experiences of a valgus brace in patients with knee osteoarthritis: A mixed-method randomised controlled trial
1. After six months, valgus brace users reported a statistically significant and clinically meaningful reduction in knee pain after walking...
Efruxifermin improves fibrosis in patients with metabolic dysfunction-associated steatohepatitis
1. Efruxifermin 50 mg once-weekly significantly improved fibrosis at 96 weeks versus placebo. 2. MASH resolution without worsened fibrosis was...
Measurement-Based Care to Enhance Antidepressant Treatment Outcomes in Major Depressive Disorder: A Randomized Clinical Trial
1. Compared to standard care, measurement-based care resulted in faster time to response and time to remission among adults with...
Pancreatic beta-cell secretory products in the diagnosis and risk stratification of gestational diabetes mellitus: a prospective longitudinal cohort study
1. 30- and 60-minute C-peptide levels during an OGTT at 16–18 weeks gestation were significantly elevated in women who later...
Beta-Blocker Use and Health Status Among Patients With Heart Failure With Preserved Ejection Fraction
1. In patients with heart failure with preserved ejection fraction (HFpEF), Beta-blocker use was not associated with concurrent baseline health...
Long-term Outcomes of Patients with Crohn’s Disease Treated with Risankizumab
1. In adult patients with Crohn’s disease (CD) treated with risankizumab, only 13% of patients experienced treatment failure while 23%...
An absence of cardiovascular risk factors is linked to over ten additional healthy years
1. In this large global cohort study, individuals aged 50 without five major cardiovascular risk factors (hypertension, hyperlipidemia, abnormal body...
